LINC00299, variants, traits, and what the research shows

LINC00299 - what this gene does

LINC00299 (long intergenic non-coding RNA 299) is a gene that produces an RNA molecule rather than a protein. Its precise biological mechanism is not characterised by the evidence available here; what the catalogued variants reveal is a pattern of statistical associations - identified primarily through GWAS (genome-wide association studies - large-scale scans that link genetic variants to traits across thousands of individuals) - spanning sleep, cancer, pharmacogenomics, metabolic conditions, rare disease, cardiovascular outcomes, and hormonal traits.

Key takeaways

• Several of the highest-magnitude variants in this gene carry sleep-trait associations, making sleep the most recurrently supported theme
• Cancer and pharmacogenomics signals also rank among the strongest entries on file
• Metabolic, rare-disease, cardiovascular, and hormonal associations extend this gene's phenotypic reach
• 87 variants are catalogued in total; most represent population-level statistical signals, not deterministic personal predictions
• Evidence strength varies across traits; replication status is not fully confirmed for all associations

Notable variants

The highest-magnitude entries (magnitude 4.50) include four sleep-linked variants - rs10929535, rs12999015, rs4669291, and rs7572890 - and two cancer-associated variants, rs115989332 and rs140194868. Pharmacogenomics signals at the same magnitude appear at rs17169 and rs186138502. A metabolic association is recorded at rs181132 and a rare-disease signal at rs2630744. Two further high-magnitude variants, rs113142991 and rs116055198, carry published pages, but their specific trait associations are not available in the current summary data.

Trait associations

Sleep traits dominate the top tier: rs10929535, rs12999015, rs4669291, and rs7572890 all carry magnitude-4.50 sleep associations - the recurrence of this theme across four independent variants strengthens confidence in the sleep signal relative to traits represented by only a single entry. Cancer appears at two distinct high-magnitude sites, rs115989332 and rs140194868, and extends to magnitude 2.20 via rs10188360; multi-variant support likewise reinforces this theme. Pharmacogenomics associations are held by rs17169 and rs186138502. Lower-magnitude entries broaden the picture: metabolic at rs181132, rare disease at rs2630744 and rs391936, cardiovascular at rs10193517, and hormonal at rs10174949.

Evidence quality

Twenty-six of the 87 catalogued variants carry prior research summaries, and several have individually published pages, indicating meaningful prior scientific and editorial review of at least a subset of associations. The sleep theme draws the broadest internal support, with four independent high-magnitude variants pointing in the same direction - the most reliable indicator of signal robustness available from this data. Cancer and pharmacogenomics each show multi-variant support at the top magnitude tier. However, quantitative details - including odds ratios, beta coefficients, cohort sizes, and replication history - are absent from the current summary data for every individual variant, making cross-trait comparison impossible here. All associations should be treated as preliminary population-level GWAS findings pending direct review of the underlying studies.

What this is NOT

These are population-level statistical associations drawn from group-level studies; they carry no deterministic predictive power for any individual's sleep, cancer risk, drug response, or any other trait. This content is informational only - no prescription, diagnosis, or personal recommendation is implied or should be inferred.